Active involvement in the European and International initiatives to improve standardisation and assays for toxicity, safety, potency and identity are priorities. Tetanus toxoid is often used as a carrier protein in new generation polysaccharide conjugate vaccines leading to over immunisation and interference. Impact to immunity is under investigation together with exploring new routes of delivery.